[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cognitive-behavior-therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cognitive-behavior-therapy":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,49,77,101,133,165,200],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100610326","the-effects-of-cognitive-behavioral-therapy-on-insulin-resistance-in-people-with-hiv-100610326",false,"NCT07226128","The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV","A Randomized, Controlled Trial Assessing the Effects of Cognitive Behavioral Therapy to Prevent Worsening Insulin Resistance in Depressed, Virologically-Suppressed, Antiretroviral-Treated Adults With HIV","Inclusion Criteria:\n\n* HIV-1 infection, documented as listed clinically in the participant's electronic medical record by any of the following tests: (1) any licensed rapid HIV test, (2) HIV enzyme test kit at any time prior to study entry, (3) at least one detectable HIV-1 antigen, or (4) at least one detectable plasma HIV-1 RNA viral load.\n* Age ≥ 18 years.\n* Ongoing receipt of stable antiretroviral therapy of any kind for at least 180 days prior to Screening\n* Meets the depression definition for this trial:\n\n  * (1) repeat PHQ-9 ≥10100 result at the Screening Visit (suggesting moderate to severe depressive symptoms), AND\n  * (2) PHQ-9 depressive disorder diagnosis (2 or more of the 9 depressive symptoms, including depressed mood or anhedonia, present in the past 2 weeks), AND\n  * (3) functional impairment (using the tenth PHQ-9 item assessing social\u002Foccupational impairment), AND\n  * (4) no evidence that the direct physiological effects of a substance, medication, or medical condition clearly account for the depressive symptoms, AND\n  * (5) no bipolar or psychotic disorders\n\nNOTE: The use of antidepressant medications is not exclusionary.\n\n* HbA1c \\\u003C 6.5% at Screening\n* HIV-1 RNA level \\\u003C 75 copies\u002FmL at Screening\n\nNOTE: There are no CD4 cell count eligibility criteria for this trial.\n\nExclusion Criteria:\n\n* Inability to complete written, informed consent\n* Inability to read and understand English as seen on a computer screen\n* Diagnosed diabetes mellitus or any previously recorded HbA1c ≥6.5%\n* History of bipolar disorder or a psychotic disorder, including schizophrenia\n\nNOTE: Depressive disorders are not exclusionary.\n\n* Incarceration at the time of any study visit\n* Active suicidality at Entry, as determined by the patient's HIV provider or social worker following a positive response (1, 2, or 3) to PHQ-9 Item #9 and a positive response (yes) to one or more of the three questions (for Question #3, the previous attempt must be within the past 10 years) on the Patient Suicidality Form (see Appendix).\n* Diagnosed disease or process, besides HIV infection, associated with increased systemic inflammation (including, but not limited to, systemic lupus erythematosus, inflammatory bowel diseases, or other collagen vascular diseases).\n\nNOTE: Hepatitis B or C co-infections are NOT exclusionary, but treatment for hepatitis C cannot be provided during study participation\n\n* End stage renal disease requiring renal replacement therapy (dialysis, transplantation).\n* Known or suspected malignancy requiring systemic treatment within 180 days of the Entry Visit.\n\nNOTE: Localized treatment for skin cancers is not exclusionary.\n\n• Therapy for serious medical illnesses within 14 days prior to the Entry Visit\n\nNOTE: Therapy for serious medical illnesses that overlaps with a study visit will result in postponement of that study visit until the course of therapy is completed; postponement outside of the allowed study visit timeframe will result in study discontinuation.\n\n* Pregnancy or breastfeeding during the study.\n* Receipt of investigational agents, cytotoxic chemotherapy, systemic immunosuppressive therapies, systemic glucocorticoids (of any dose), or anabolic steroids at the Entry Visit\n\nNOTE: Physiologic testosterone replacement therapy or topical steroids is not exclusionary. Inhaled\u002Fnasal steroids are not exclusionary as long as the participant is not also receiving HIV protease inhibitors\n\nNOTE: Use of NSAIDS and aspirin are allowed\n\n• Active drug use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements.","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to learn if depression treatment improves insulin resistance, or how the body uses insulin to lower blood sugar, in people with HIV on HIV treatment. Researchers will compare an internet-based (online) depression treatment program called cognitive behavioral therapy with depression education. In the online group, participants will undergo 9 weekly treatment sessions. The education group will receive learning materials about depression and will be monitored every month. All participants will have 4 study visits over 12 months.",[26,27,28,29],"HIV","Depression in Adults","Insulin Resistance","Cognitive Behavior Therapy",[31,32,33,34,35],"hiv","depression","insulin resistance","diabetes","cognitive behavioral therapy","RECRUITING","2026-05-31",{"date":39,"type":40},"2026-06-02","ACTUAL",{"date":42,"type":40},"2026-04-10",{"date":44,"type":20},"2031-06-30",{"name":46,"class":47},"Indiana University","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":21,"phases":59,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":48},"100624365","mechanisms-of-change-in-psychotherapy-the-effects-of-cognitive-behavioral-therapy-and-psychodynamic-therapy-in-once---versus-twice---weekly-sessions-on-outcomes-in-depression-100624365","NCT07408687","Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - Versus Twice - Weekly Sessions on Outcomes in Depression.","MOP II","Inclusion criteria:\n\n* age 18-65 years\n* Major Depressive Disorder Hamilton Depression Rating Scale (HDRS) \\> 14.\n* Speak and understand a Scandinavian language\n* Willingness and ability to give informed consent.\n\nExclusion Criteria:\n\n* Current or past neurological illness\n* Traumatic brain injury\n* Current alcohol and\u002For substance dependency disorders\n* Psychotic disorders\n* Bipolar disorders\n* Developmental disorders\n* IQ \\\u003C70.","65 Years",{"count":58,"type":20},200,[23],"The MOP II study examines how to improve therapy for people struggling with a depressive disorder. Cognitive Behavioral Therapy (CBT) and Short-Term Psychodynamic Psychotherapy (STPP) are two evidence-based treatments for depression that are widely used. Meta-analyses indicate that CBT and STPP are one average equally effective and superior to no treatment. However, many patients do not respond sufficiently and relapse rates after acute phase treatment are high.\n\nEarlier research and theoretical insights suggest three promising strategies to enhance the effectiveness of psychotherapy. First, we want to examine whether increasing the frequency of the sessions will increase the effect of therapy. We want to compare once-weekly and twice-weekly sessions in both CBT and STPP to see whether more frequent sessions lead to better and more lasting reductions in depressive symptoms with the same total number of sessions.\n\nSecond, the study aims to answer what works for whom in two different psychotherapeutic approaches. People with depression differ in personality, life experiences, relationship styles, and how they understand the causes of their depression. Previous findings suggest that patients do better when the therapy approach matches how they see their problems. The MOP II study wants to replicate this finding.\n\nThird, the study wants to examine how therapy leads to change. In CBT, improvement is thought to happen through changes in thinking patterns, such as fewer negative automatic thoughts and less rumination. In STPP, change is expected to come from better self-understanding, greater emotional awareness, and healthier ways of relating to others.\n\nConsequently, the goal of the MOP II study is to find out whether more frequent therapy, better matching of patients to treatment type, and a clearer understanding of how therapy works can lead to faster improvement of depressive symptoms.",[62,29,63],"Depression - Major Depressive Disorder","Psychodynamic Therapy",[65,66],"Mechanisms of change in Psychotherapy","Frequency of therapy sessions","NOT_YET_RECRUITING","2026-02-13",{"date":70,"type":40},"2026-02-18",{"date":72,"type":20},"2026-03-01",{"date":74,"type":20},"2030-12-31",{"name":76,"class":47},"University of Oslo",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":21,"phases":88,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":4},"100618888","evidence-based-digital-cbt-for-nonsuicidal-self-injury-100618888","NCT07337473","Evidence-based Digital CBT for Nonsuicidal Self-Injury","Effect of Evidence-based Digital Cognitive Behavior Therapy for Adolescents With Nonsuicidal Self-Injury Disorder: A Randomized Clinical Trial","Inclusion Criteria:\n\n* 5 nonsuicidal self-injury episodes past year\n* 1 nonsuicidal self-injury episodes past month having at least one parent who committed to participate in the program\n\nExclusion Criteria:\n\nSevere suicidal ideation a diagnosis of psychotic or ongoing (past month) substance dependence the presence of co-occurring psychological disorders that required immediate treatment (i.e., severe anorexia nervosa)","12 Years","25 Years",{"count":87,"type":20},100,[23],"To evaluate if evidence-based digital cognitive behaviour therapy for adolescents is an efficacious treatment when delivered as an adjunctive treatment to treatment as usual, compared to a control group consisting of treatment as usual.",[91,29],"Non Suicidal Self Injury","2026-01-04",{"date":94,"type":40},"2026-01-13",{"date":96,"type":20},"2026-01-31",{"date":98,"type":20},"2027-01-30",{"name":100,"class":47},"Peking University Sixth Hospital",{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":107,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":16,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":4,"studyType":21,"phases":113,"briefSummary":114,"conditions":115,"keywords":119,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":48},"100611788","virtual-reality-exposure-therapy-for-obsessive-compulsive-disorder-a-randomized-controlled-trial-in-inpatients-100611788","NCT07245134","Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients","Virtual Reality Exposure Therapy in Patients With Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients","OCD-VRET1","Inclusion Criteria:\n\n* Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11\n* Fluent in Czech\n\nExclusion Criteria:\n\n* Any other psychiatric, neurological and serious somatic illness\n* Substance abuse\n* Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics.\n* Contradictions to using a virtual reality (e.g., epilepsy, balance problems)\n* Pregnancy\n* Cardiostimulator and mental implants","17 Years","55 Years",{"count":112,"type":20},62,[23],"The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly assigned to one of the following interventions: a) exposure condition - the group with a standard CBT program enriched with exposure therapy in VR (VRET), b) control condition 1 - the group with a standard CBT program enriched with VR cognitive training aimed at cognitive flexibility or c) control condition 2 - standard CBT program without any additional VR intervention. The treatment effect will be evaluated using pre\u002Fpost assessments, as well as monitoring adherence to exposure and response prevention assignments.",[116,117,118,29],"Obsessive-Compulsive Disorder","Virtual Reality Exposure Therapy","Virtual Reality Cognitive Training",[120,121,122,123],"obsessive-compulsive disorder","VR exposure therapy","cognitive flexibility","Inpatient clinic","2025-11-20",{"date":126,"type":40},"2025-11-24",{"date":128,"type":40},"2022-11-15",{"date":130,"type":20},"2026-12-30",{"name":132,"class":47},"National Institute of Mental Health, Czech Republic",{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":140,"enrollmentInfo":141,"targetDuration":4,"studyType":21,"phases":143,"briefSummary":144,"conditions":145,"keywords":151,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":156,"lastUpdatePostDateStruct":157,"startDateStruct":159,"completionDateStruct":161,"leadSponsor":163,"locationsCount":48},"100592637","effects-of-snags--cbt-on-pain-craniovertebral-angle--disability-in-non-specific-neck-pain-100592637","NCT06996015","Effects of SNAGs & CBT on Pain, Craniovertebral Angle & Disability in Non Specific Neck Pain","Effects of SNAGs and Cognitive Behavior Therapy on Pain, Craniovertebral Angle and Disability in Patients With Non-Specific Neck Pain","Inclusion Criteria:\n\n* Age group: 18-28 Years(20)\n* Gender Group: Both male and female participants(20)\n* Individuals with a Craniovertebral angle \\\u003C53(20)\n* Individuals having grade 2 neck pain according to KNGF Guidelines.(21)\n* Individuals having localized pain or stiffness in spine or both combined between C3 and C7 without upper-limb radiculopathy(22)\n* Individual who had not received any treatment for neck pain for the last 3 months will be included in the study.\n* Patients willing to sign written consent form.\n\nExclusion Criteria:\n\n* Those who had undergone spinal surgery(23)\n* Neck pain caused by various pathologies (rheumatoid arthritis, ankylosing spondylitis, fracture, tumor, etc.)(23)\n* Nerve root compression, (23)\n* A positive vertebrobasilar artery test, (23)\n* Severe radiculopathy,(23)\n* Osteoporosis, or osteopenia(23)\n* Long-term use of corticosteroids or anticoagulants (23)","28 Years",{"count":142,"type":20},32,[23],"Non-specific neck pain is a prevalent condition causing discomfort, reduced craniovertebral angle, and disability. This randomized controlled trial will evaluate the combined effects of Sustained Natural Apophyseal Glides (SNAGs) and Cognitive Behavioral Therapy (CBT) on pain, posture, and function. Group A will receive SNAGs and CBT, while Group B will undergo SNAGs with cervical stabilization exercises, twice weekly for four weeks. Outcomes will include pain, craniovertebral angle, and disability, analyzed using SPSS.",[146,29,147,148,149,150],"Neck Pain","Cervicalgia","Posture","Posterior Neck Pain","Neck Pain and Forward Head Posture",[152,153,154,155],"snags","Non-Specific Neck Pain","Craniovertebral Angle","disability","2025-07-03",{"date":158,"type":40},"2025-07-04",{"date":160,"type":40},"2025-06-10",{"date":162,"type":20},"2025-12-10",{"name":164,"class":47},"Riphah International University",{"id":166,"slug":167,"hasResults":11,"nctId":168,"briefTitle":169,"officialTitle":170,"acronym":4,"eligibilityCriteria":171,"healthyVolunteers":11,"sex":16,"minAge":172,"maxAge":173,"enrollmentInfo":174,"targetDuration":4,"studyType":21,"phases":175,"briefSummary":176,"conditions":177,"keywords":182,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":190,"lastUpdatePostDateStruct":191,"startDateStruct":193,"completionDateStruct":195,"leadSponsor":197,"locationsCount":48},"100591506","internet-delivered-psychological-treatments-for-chronic-pain-in-adolescents-act-and-pain-education-100591506","NCT06981312","Internet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education.","Internet-Delivered Acceptance and Commitment Therapy for Chronic Pain in Adolescents: A Randomized Controlled Trial.","Inclusion Criteria:\n\n* Adolescents aged 13-19 years with chronic pain (duration ≥ 3 months).\n* Have undergone a medical examination regarding their pain condition.\n* Are not using pain-relieving medication, or have been stable on such medication for at least 2 months, with no planned medication changes.\n* Have not undergone ACT or CBT treatment in the past six months.\n* Can read and write in Swedish without difficulty.\n* Have access to a smartphone\u002Fcomputer with an internet connection and e-ID.\n* Have at least one parent or guardian who is willing and able to participate in parallel parent support treatment.\n\nExclusion Criteria:\n\n* Insufficient understanding of Swedish to complete study-related tasks.\n* Adolescents currently undergoing ACT or CBT treatment.\n* Adolescents who are using pain-relieving medication or have unstable medication regimes.\n* Adolescents without access to a smartphone\u002Fcomputer or e-ID.","13 Years","19 Years",{"count":19,"type":20},[23],"One in four children in Sweden experiences chronic pain. For many, the pain is temporary, but for about 5% it significantly affects daily life, leading to sleep problems, school absence, and reduced physical activity. Youth with chronic pain report lower life satisfaction and overall health compared to their peers. In most cases, there is no underlying disease or injury, suggesting that chronic pain is a condition in itself, driven by dysregulation in the pain system and influenced by biological, psychological, and social factors.\n\nNational guidelines in Sweden recommend cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) for children and adolescents with chronic pain and substantial functional limitations. However, more high-quality randomized controlled trials (RCTs) are needed to strengthen the evidence base for these treatments.\n\nThe investigators' clinic has developed and evaluated ACT-based treatments for pediatric chronic pain over the past two decades. The protocol has now been adapted into an internet-delivered version to increase accessibility. In a preliminary feasibility study, the investigators observed promising effects on pain interference, though some usability issues have since been addressed.\n\nThe treatment is grounded in the fear-avoidance model, which explains how avoidance of pain-related activities can worsen disability over time. In ACT, such avoidance is seen as driven by unwanted thoughts, emotions, and bodily sensations. The aim of treatment is to help young people relate more flexibly to pain and fear and to move toward personally meaningful goals - a skill referred to as psychological flexibility. Exposure is a core component of ACT, encouraging patients to engage with avoided thoughts, feelings, and activities in order to reduce avoidance and improve functioning.\n\nIn addition to treating the young person, the study also targets parental behaviors. Parents often respond to their child's pain by increasing protection and monitoring, which is natural but can sometimes contribute to further avoidance and reduced independence in the child. ACT-based parent support is designed to help caregivers support their child more effectively.\n\nIn this randomized trial, internet-delivered ACT will be compared to two control conditions: (1) an active comparator involving online pain education, and (2) a passive control group on a wait list. The pain education intervention is based on Pain Science Education (PSE), which aims to shift how individuals understand their pain - from seeing it as a sign of injury to recognizing it as a false alarm in the nervous system. PSE has shown promising effects in adults, but research in youth is still limited, and no RCTs have yet been published.\n\nThe study responds to the need for well-designed digital interventions that reach more young people, evaluate treatment components more clearly, and include comparison groups that also receive digital interventions. The goal of the study is to further improve treatment effects by (1) emphasizing exposure strategies to reduce avoidance, (2) expanding pain education to enhance treatment understanding, and (3) refining parent support to better help families manage chronic pain over the long term.\n\nThe project aims to increase knowledge about the effects of psychological treatments - in this case delivered online - for adolescents with chronic pain. As previous studies have highlighted the promise of exposure-based strategies and digital accessibility, the study aims to evaluate the effect of a treatment that combines and optimizes both. The study also aims to better understand the specific impact of pain education as a stand-alone intervention, as this is a growing research field with limited studies in youth. Regarding the parent support component of ACT, the study will evaluate whether changes in parental behaviors related to their child's pain are associated with reduced parenting stress and improved functioning and quality of life in the adolescents. In addition to evaluating treatment outcomes, the study aims to explore the underlying processes that may contribute to the effects of ACT and pain education.",[178,179,180,181,29],"Chronic Pain","Nociplastic Pain","Pain Management","Acceptance and Commitment Therapy",[183,184,178,179,180,181,29,185,186,187,188,189],"Pain Science Education","Pain Education","Adolescent","Parent-Child Relations","Psychological Flexibility","iCBT","Telemedicine","2025-05-13",{"date":192,"type":40},"2025-05-20",{"date":194,"type":20},"2025-05",{"date":196,"type":20},"2027-12",{"name":198,"class":199},"Region Stockholm","OTHER_GOV",{"id":201,"slug":202,"hasResults":11,"nctId":203,"briefTitle":204,"officialTitle":205,"acronym":4,"eligibilityCriteria":206,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":207,"targetDuration":4,"studyType":21,"phases":209,"briefSummary":210,"conditions":211,"keywords":213,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":216,"lastUpdatePostDateStruct":217,"startDateStruct":219,"completionDateStruct":221,"leadSponsor":222,"locationsCount":48},"100570934","the-impact-of-culture-in-cognitive-behavior-therapy-cbt-for-patients-with-inflammatory-bowel-disease-100570934","NCT06713694","The Impact of Culture in Cognitive Behavior Therapy (CBT) for Patients With Inflammatory Bowel Disease","The Effectiveness of Cognitive Behavioral Therapy on Anxiety, Depression, and Stigma Among Chinese Patients With Inflammatory Bowel Disease Across Diverse Cultural Identities:Protocol for a Pilot Randomised Controlled Trial","Inclusion Criteria:\n\n1. Patients over 18 years of age with diagnosed IBD.\n2. Age: 18 years and older.\n3. residing in China, able to verbally communicate and read in Chinese, with access to the internet to ensure participation in the online intervention.\n4. Able to commit to attend the 6weekly sessions of 1 hours' duration.\n5. No change in antidepressant medication (dose or type) within 3 months of trial onset.\n\nExclusion Criteria:\n\n1. Individuals scheduled for major surgery in the next 3 months.\n2. Current psychological treatment.\n3. Individuals with severe schizophrenia\u002Fpsychotic disorder.",{"count":208,"type":20},40,[23],"Introduction Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic condition that affects the gastrointestinal tract and has a significant impact on patients' quality of life (QoL) and mental health(Barberio, Zamani et al. 2021). Cognitive behavioral therapy (CBT) has been recognized as a potential therapeutic approach to address the psychological comorbidities associated with IBD(Seaton, Hudson et al. 2024). However, the effectiveness of CBT in IBD is not solely a clinical issue but is also intertwined with cultural factors that can influence treatment outcomes(Naeem 2019).\n\nThe effectiveness of CBT in IBD is not solely a clinical issue but is also intertwined with cultural factors that can influence treatment outcomes . This has implications for the delivery of CBT in IBD care, as cultural beliefs and values can affect help-seeking behaviors and responses to treatment. Cultural factors are integral to the successful implementation of CBT in IBD care(Hinton and Patel 2017, Naeem, Sajid et al. 2023). Further research is needed to understand how cultural adaptations can enhance the efficacy of CBT for IBD patients from diverse backgrounds. It is essential to consider cultural nuances in the development and delivery of CBT to ensure that it is both effective and acceptable to patients with IBD across different cultures.\n\nObjective: To identify gaps in the current understanding of the role of culture in CBT for IBD, including the variety of cultural contexts and IBD populations studied . To provide insights that can guide clinical practice in offering culturally competent CBT to IBD patients and inform policy decisions regarding mental health services for diverse populations with IBD .",[212,29],"Inflammatory Bowel Disease (IBD)",[214,215],"inflammatory bowel disease","cognitive behavior therapy","2025-04-11",{"date":218,"type":40},"2025-04-16",{"date":220,"type":20},"2025-08-01",{"date":130,"type":20},{"name":223,"class":47},"Wang Zhen"]